phase readout
saveNCT07215234: A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: Sanofi. Phase: PHASE1. Conditions: Geographic Atrophy
view source ↗
comments(0)
5-min edit window · permanent after that